Genetically engineered T cells having improved persistence in culture
US-12344656-B2 · Jul 1, 2025 · US
This page is not indexed by search engines while we improve data quality.
Waldner Hanspeter patents
Waldner Hanspeter is listed as an inventor on 8 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Waldner Hanspeter |
| Total patents | 8 |
| First publication | Feb 12, 2015 |
| Latest publication | Jul 1, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Multiplex gene edited cells for cd70-directed cancer immunotherapy
US-2023390392-A1 · Dec 7, 2023 · US
Genetically engineered t cells with disrupted casitas b-lineage lymphoma proto-oncogene-b (cblb) and uses thereof
US-2023346836-A1 · Nov 2, 2023 · US
Genetically engineered t cells having improved persistence in culture
US-2021079347-A1 · Mar 18, 2021 · US
Methods related to tim 3, a th1-specific cell surface molecule, for activating antigen presenting cells
US-2018271977-A1 · Sep 27, 2018 · US
Methods related to TIM 3, a Th1-specific cell surface molecule, for activating antigen presenting cells
US-9333256-B2 · May 10, 2016 · US
Methods related to tim 3, a th1-specific cell surface molecule, for activating antigen presenting cells
US-2015044230-A1 · Feb 12, 2015 · US
Methods related to tim 3, a th1-specific cell surface molecule, for activating antigen presenting cells
US-2015044229-A1 · Feb 12, 2015 · US
Recent patents
Latest publications not already listed above.
No data yet.
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Dana Farber Cancer Inst Inc | 5 |
| Crispr Therapeutics Ag | 4 |
| Brigham & Womens Hospital | 3 |
| Brigham & Womens Hospital Inc | 1 |
| Nkarta Inc | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 8 |
| A61K2039/505 | 5 |
| A61P3/10 | 4 |
| A61P37/08 | 4 |
| A61P43/00 | 4 |